882 related articles for article (PubMed ID: 9218010)
1. Hyperthermia potentiates antitumor effect of thermosensitive-liposome-encapsulated melphalan and radiation in murine melanoma.
Chelvi TP; Ralhan R
Tumour Biol; 1997; 18(4):250-60. PubMed ID: 9218010
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.
Chelvi TP; Jain SK; Ralhan R
Oncol Res; 1995; 7(7-8):393-8. PubMed ID: 8747602
[TBL] [Abstract][Full Text] [Related]
3. Heat-mediated selective delivery of liposome-associated melphalan in murine melanoma.
Chelvi PT; Jain SK; Ralhan R
Melanoma Res; 1995 Oct; 5(5):321-6. PubMed ID: 8541722
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma.
Sharma D; Chelvi TP; Kaur J; Ralhan R
Melanoma Res; 1998 Jun; 8(3):240-4. PubMed ID: 9664145
[TBL] [Abstract][Full Text] [Related]
5. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
[TBL] [Abstract][Full Text] [Related]
6. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the response of B16F1 melanoma to fractionated radiotherapy and prolongation of survival by withaferin A and/or hyperthermia.
Kalthur G; Pathirissery UD
Integr Cancer Ther; 2010 Dec; 9(4):370-7. PubMed ID: 20713375
[TBL] [Abstract][Full Text] [Related]
9. Designing of thermosensitive liposomes from natural lipids for multimodality cancer therapy.
Chelvi TP; Ralhan R
Int J Hyperthermia; 1995; 11(5):685-95. PubMed ID: 7594819
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
[TBL] [Abstract][Full Text] [Related]
11. Targeting chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthermia.
Kakinuma K; Tanaka R; Takahashi H; Watanabe M; Nakagawa T; Kuroki M
J Neurosurg; 1996 Feb; 84(2):180-4. PubMed ID: 8592219
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.
Lokerse WJ; Bolkestein M; Ten Hagen TL; de Jong M; Eggermont AM; Grüll H; Koning GA
Theranostics; 2016; 6(10):1717-31. PubMed ID: 27446503
[TBL] [Abstract][Full Text] [Related]
14. Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma.
Clark J; Grabs AJ; Parsons PG; Smithers BM; Addison RS; Roberts MS
Melanoma Res; 1994 Dec; 4(6):365-70. PubMed ID: 7703715
[TBL] [Abstract][Full Text] [Related]
15. Effects of hyperthermia and irradiation on the growth of mouse melanoma tumors following immunotherapy.
Green DM; Samulski TV; Vervaert C; Halperin EC; Oleson JR; Seigler H
J Surg Oncol; 1990 Aug; 44(4):256-9. PubMed ID: 2385103
[TBL] [Abstract][Full Text] [Related]
16. Thermochemotherapy for B16 melanoma: combination therapy of hyperthermia, melphalan, and CCNU in mice.
Vicente V; Gomez M; Ochotorena MM; Cremades A; Canteras M
Pigment Cell Res; 1990; 3(1):1-7. PubMed ID: 2377576
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
[TBL] [Abstract][Full Text] [Related]
18. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
[TBL] [Abstract][Full Text] [Related]
19. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.
Nishimura Y; Ono K; Hiraoka M; Masunaga S; Jo S; Shibamoto Y; Sasai K; Abe M; Iga K; Ogawa Y
Radiat Res; 1990 May; 122(2):161-7. PubMed ID: 2336462
[TBL] [Abstract][Full Text] [Related]
20. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
